At the IMCAS PARIS 2024 held at the Palais des Congress Convention Center in Paris, France, for a total of three days from Feb. 1 to Feb. 3, CHAMEDITECH had a meaningful time to announce the differentiate between its main products, DOROTHY DEWY.

CHAMEDITECH set up an exhibition booth to promote products and brands to overseas medical staff and industry officials, including Europe and the Middle East. Among them, it mainly introduced "DOROTHY," a line of hyaluronic acid (HA) fillers, and "CELLTERMI REVIVE NX," a topical skin booster.

On the 3rd, the last day of the event, Dr. Huray Hugul of Turkiye and Dr. Vaxques Casas of Spain were invited to hold an exclusive symposium under the theme "How to make the skin glow with soft injection."

The symposium introduced procedural protocols and clinical cases using DOROTHY on the site of the procedure and revealed the findings of DOROTHY's strengths over other HA fillers.

Meanwhile, DOROTHY is a product that CHAMEDITECH has implemented optimized physical properties for improving fine wrinkles through research for more than 10 years, and has recently attracted great attention in Korea.

DOROTHY can fill the skin with hyaluronic acid, which contains 20mg of high-dose hyaluronic acid (HA), which is effective in expressing glowing skin, and overseas consumers are looking for it because it has a longer maintenance period than other skin boosters that give water-luminous effects.